Validation of cardiovascular disease risk prediction models using population-wide electronic health records for England post COVID-19 pandemic: the SCORE2 family-of-models

3 April 2025 (15:30 - 16:15)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Miss Carmen Petitjean

Cambridge (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail

Combining the systematic coronary risk evaluation (SCORE2-SCORE2-OP) with anthropometric measures to refine 10-year cardiovascular prediction in a population-based cohort study

Miss J. Lopes Oliveira (Lausanne, CH)

Abstract Slides

Presentation thumbnail

Assessment of CV risk by SCORE2 with an online calculator estimates CV risk better compared to 2-dimensional risk charts

Doctor S. Hageman (Utrecht, NL)

Abstract Slides

Presentation thumbnail

Risk stratification in chronic coronary syndrome: real-world application of SMART and EUROASPIRE scores for treatment optimization

Assistant Professor M. German-Sallo (Targu Mures, RO)

Abstract Slides

Presentation thumbnail

Validation of the European SCORE2 algorithm in four European and non-European cohort studies with contrasting populations

Doctor K. Maung (Lausanne, CH)

Abstract Slides

Presentation thumbnail

Risky business: exploring statin eligibility across nine cardiovascular risk prediction models

Mr P. Navickas (Vilnius, LT)

Abstract Slides

Access the full session

Session thumbnail

Estimating cardiovascular risk: does one score fit all?

The Event

Event poster

ESC Preventive Cardiology 2025

3 April 2025 15:30 CET

You may be interested in

Webinar

Risk assessment and lipid management in primary prevention

Webinar

Unmet needs in lipid management: treatment goals and how to achieve them

Webinar

Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources